Shenzhen Click Technology (002782.SZ)'s 2026 targeted issuance application accepted by Shenzhen Stock Exchange
Click Technology (002782.SZ) announced that on September 24, 2026, the company received the "Notice on Accepting the Application Documents for Issuing Shares to Specific Targets by Shenzhen Click Technology Co., Ltd." issued by the Shenzhen Stock Exchange (referred to as the "SZSE"). The SZSE reviewed the application documents submitted by the company for issuing shares to specific targets and determined that the application documents were complete, and decided to accept them.
Shenzhen Click Technology (002782.SZ) announced that on September 24, 2026, the company received the "Notice on Accepting the Application Documents for the Issuance of Shares to Specific Targets by Shenzhen Click Technology Co., Ltd." issued by the Shenzhen Stock Exchange (referred to as the "SZSE"). The SZSE reviewed the application documents submitted by the company for the issuance of shares to specific targets and determined that the application documents were complete, and decided to accept them.
Related Articles
Sichuan Biokin Pharmaceutical (688506.SH): T-Bren included in the breakthrough therapy designation list
Sichuan Biokin Pharmaceutical (688506.SH): BL-M05D1 for Injection Included in the Breakthrough Therapy Designation List
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): T-Bren included in the breakthrough therapy designation list
Sichuan Biokin Pharmaceutical (688506.SH): BL-M05D1 for Injection Included in the Breakthrough Therapy Designation List
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
